A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
AstraZeneca
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Dana-Farber Cancer Institute
Day One Biopharmaceuticals, Inc.
Bayer
National Cancer Institute (NCI)
City of Hope Medical Center
Quadriga Biosciences, Inc.
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tocagen Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Novartis
Roswell Park Cancer Institute
University of South Florida
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center